What the format contains
Digital delivery is a route for providing an intervention, not an intervention in its own right. In the clinician-supported internet CBT reviewed by Hedman-Lagerlöf et al. (2023), adults worked through structured materials and assignments with therapist feedback. The relevant comparison was a full course of face-to-face CBT. Across 31 randomized trials, the pooled symptom difference was close to zero, g = 0.02 (95% CI −0.09 to 0.14). This supports similarity on average in the studied settings. It does not establish that any app is equivalent to psychotherapy, that all diagnoses have equally extensive evidence, or that therapist contact can simply be removed. Clinician involvement, treatment dose and the actual comparison belong beside any public statement about digital effectiveness.
Sources: Hedman-Lagerlöf et al., 2023
Guidance and the person receiving treatment
Karyotaki et al. (2021) used individual participant data to compare guided and unguided depression programs. Guidance had a modest average short-term advantage, with more apparent benefit at greater baseline symptom severity; the analysis did not establish a guided–unguided difference at six or twelve months. The practical implication is conditional: some people may benefit from self-directed structured care, while others need more support. The review excluded smartphone-only interventions. Its results therefore cannot be carried over unchanged to a mobile journal, a conversational assistant or a person with a different clinical presentation. The appropriate unit of evidence is the tested program in its population, not the broad label “online CBT.”
Sources: Karyotaki et al., 2021
App effects and the comparison that produces them
The broader smartphone-app literature is more heterogeneous. Linardon et al. (2024) found small average effects on depression and generalized-anxiety symptoms across 176 trials. Comparisons with active interventions were fewer and did not establish app superiority. Most endpoints were short-term, and dropout was substantial. An app may therefore look promising against waiting while adding little over another credible intervention. Statistical averages do not identify which commercial product helps an individual, and feature-level moderator associations do not demonstrate that adding a chatbot or mood tracker causes a better outcome. These distinctions are important when describing features: a plausible design choice is different from a clinically validated product claim.
Sources: Linardon et al., 2024
Journaling is a narrower and less settled claim
Journaling research includes expressive writing and gratitude exercises with different instructions, schedules and outcomes. Sohal et al. (2022) identified randomized evidence but emphasized heterogeneity and methodological weaknesses. This supports further study and a possible adjunctive role; it does not justify a universal recovery percentage or establish that a digital thought record has the same effect as a course of CBT. A thought record, free writing and symptom monitoring should be described according to what the person actually does. For product communication, “provides guided reflection prompts” is a feature description; “treats depression” is an outcome claim needing direct evidence. The latter cannot be inferred from the presence of a journal.
Sources: Sohal et al., 2022
What negative findings and follow-up add
The REEACT pragmatic trial is an important counterweight to a uniformly positive account. The tested computerised programs did not outperform usual primary care in that implementation (Gilbody et al., 2015). This does not overturn every internet-CBT trial; it shows why support, uptake and the surrounding service matter. Longer-term evidence also deserves its own discussion. Zainal et al. (2024) synthesized trials with follow-up of at least a year, extending the question beyond immediate symptom change. That review overlaps earlier digital-treatment trial pools, so its participants cannot be added to earlier totals as though they were independent replications. Maintenance, relapse and subsequent treatment use are distinct outcomes that require explicit measurement.
Sources: Gilbody et al., 2015; Zainal et al., 2024
Interpretation for this company and remaining questions
For Umbrella Journal and Nuggets, the immediate research value is to explain the purpose of reflective exercises and habit supports without converting technique-level findings into product efficacy. For Ella, a conversational interface does not establish equivalence to either guided iCBT or clinical care. This is an editorial inference from the differences in intervention definitions and study comparators above. Useful next studies would specify a product version, a target population and a credible control; assess functioning alongside symptoms; account for people who stop using the product; and follow participants after the initial novelty period. Adherence, accessibility and adverse experiences should be reported as outcomes, rather than treated as explanations only when results disappoint.
Sources: Karyotaki et al., 2021; Hedman-Lagerlöf et al., 2023; Linardon et al., 2024; Sohal et al., 2022; Gilbody et al., 2015; Zainal et al., 2024
References
Links open the original papers or official sources. Access labels describe the material assessed for this review.
Hedman-Lagerlöf, E., Carlbring, P., Svärdman, F., Riper, H., Cuijpers, P., & Andersson, G. (2023). Therapist-supported Internet-based cognitive behaviour therapy yields similar effects as face-to-face therapy for psychiatric and somatic disorders: An updated systematic review and meta-analysis. World Psychiatry, 22(2), 305–314. 10.1002/wps.21088
Access assessed: Publisher full text; selected methods and results inspected
Karyotaki, E., Efthimiou, O., Miguel, C., Maas genannt Bermpohl, F., Furukawa, T. A., Cuijpers, P., & Individual Patient Data Meta-Analyses for Depression (IPDMA-DE) Collaboration (2021). Internet-based cognitive behavioral therapy for depression: A systematic review and individual patient data network meta-analysis. JAMA Psychiatry, 78(4), 361–371. 10.1001/jamapsychiatry.2020.4364
Access assessed: Publisher full text; selected methods, results, funding and correction inspected
Linardon, J., Torous, J., Firth, J., Cuijpers, P., Messer, M., & Fuller-Tyszkiewicz, M. (2024). Current evidence on the efficacy of mental health smartphone apps for symptoms of depression and anxiety. A meta-analysis of 176 randomized controlled trials. World Psychiatry, 23(1), 139–149. 10.1002/wps.21183
Access assessed: Publisher full text; results, comparators, dropout and limitations inspected
Sohal, M., Singh, P., Dhillon, B. S., & Gill, H. S. (2022). Efficacy of journaling in the management of mental illness: A systematic review and meta-analysis. Family Medicine and Community Health, 10(1), e001154. 10.1136/fmch-2021-001154
Access assessed: Indexed PubMed abstract and publisher PDF excerpts; complete full-text audit unavailable
Gilbody, S., Littlewood, E., Hewitt, C., Brierley, G., Tharmanathan, P., Araya, R., Barkham, M., Bower, P., Cooper, C., Gask, L., Kessler, D., Lester, H., Lovell, K., Parry, G., Richards, D. A., Andersen, P., Brabyn, S., Knowles, S., Shepherd, C., … White, D. (2015). Computerised cognitive behaviour therapy (cCBT) as treatment for depression in primary care (REEACT trial): Large scale pragmatic randomised controlled trial. BMJ, 351, h5627. 10.1136/bmj.h5627
Access assessed: Publisher indexed abstract and PDF extracts; direct full text returned 403
Zainal, N. H., Soh, C. P., Van Doren, N., & Benjet, C. (2024). Do the effects of internet-delivered cognitive-behavioral therapy (i-CBT) last after a year and beyond? A meta-analysis of 154 randomized controlled trials (RCTs). Clinical Psychology Review, 114, 102518. 10.1016/j.cpr.2024.102518
Access assessed: PubMed abstract and author-repository abstract/PDF excerpts; repository open challenged
This evidence review is educational. It does not provide an individual diagnosis or treatment plan. Read the review methods, access limits, and clinical-review status.